Many patients experience benefits that persist for several months after completing a full treatment cycle, especially when supported by healthy lifestyle habits
Chang CH, Tsai WC, Hsu YH, Pang JHS
Conclusions Recently, many compounds, discovered through computer-based gene-profiling, were proposed as novel therapeutics
Clinical evidence shows that glutathione IV therapy can improve liver markers, such as decreasing ALT (a liver inflammation indicator), and enhance cellular repair, especially beneficial for conditions like fatty liver disease
Another study used P38 kinase inhibitors to develop a pharmacophore model, which demonstrated their strong binding affinity at the P38 active site
Synbiotics, as well as the combination of probiotics with postbiotics or conventional drugs, all demonstrate therapeutic potential for liver diseases